Understanding health disparities in patients with Fragile X syndrome from different racial and ethnic backgrounds
Official title: Health Disparities of Patients with Fragile X from Diverse Racial & Ethnic Groups
Funded at Wake Forest University Health Sciences · NIH-11029872 · Data updated 2026-11-12
This study is looking at how Fragile X syndrome affects people from different backgrounds and aims to find better ways to diagnose and treat it, so that everyone gets the care they need.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Wake Forest University Health Sciences NIH-funded |
| Lab location | 1 site (Winston-Salem, United States) |
| Project start | April 6, 2023 |
| Project end | March 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $75,501 |
| NIH project number | 7R03HD111720-02 |
| Project ID | NIH-11029872 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals diagnosed with Fragile X syndrome or those who may be at risk due to family history, particularly from diverse racial and ethnic backgrounds.
✕Less likely to help
Patients without Fragile X syndrome or those not belonging to the studied racial and ethnic groups may not receive direct benefits from this research.
What this research studies
This research investigates the health characteristics and disparities of individuals with Fragile X syndrome (FXS) across diverse racial and ethnic groups. By analyzing electronic health records from over 15 million patients, the study aims to identify underdiagnosed cases of FXS and develop innovative pre-screening methods to improve diagnosis and treatment. The research will provide valuable insights into the prevalence of co-occurring conditions and the overall impact of FXS on health and well-being. Ultimately, it seeks to enhance diagnostic practices for FXS and similar complex conditions.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnosis and management of Fragile X syndrome, benefiting patients and their families.
How similar studies have gone: Previous research has shown success in identifying health disparities in genetic conditions, making this approach both relevant and promising.
Where this research is happening
-
Wake Forest University Health Sciences
Winston-Salem, United States Active
Researchers
- Principal investigator: Movaghar, Arezoo — Wake Forest University Health Sciences
- Study coordinator: Movaghar, Arezoo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.